Lpl Financial LLC Abb Vie Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 2,657,804 shares of ABBV stock, worth $474 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,657,804

Previous 2,565,312 3.61%

Holding current value

$474 Million

Previous $440 Million 19.29%

% of portfolio

0.24%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $15.2 Million - $18.4 Million	92,492 Added 3.61%	2,657,804 $525 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $18.8 Million - $22 Million	121,492 Added 4.97%	2,565,312 $440 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $11.5 Million - $13.1 Million	-72,081 Reduced 2.87%	2,443,820 $445 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $10.4 Million - $11.7 Million	75,375 Added 3.09%	2,515,901 $390 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $21.4 Million - $24.8 Million	160,253 Added 7.03%	2,440,526 $364 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $2.18 Million - $2.72 Million	-16,480 Reduced 0.72%	2,280,273 $307 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $21.7 Million - $25 Million	149,891 Added 6.98%	2,296,753 $366 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $15.5 Million - $18.6 Million	112,195 Added 5.51%	2,146,862 $347 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $10.3 Million - $11.8 Million	76,556 Added 3.91%	2,034,667 $273 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $4.95 Million - $6.29 Million	-35,949 Reduced 1.8%	1,958,111 $300 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $5.61 Million - $6.97 Million	42,541 Added 2.18%	1,994,060 $323 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $14.5 Million - $18.4 Million	135,002 Added 7.43%	1,951,519 $264 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $16.3 Million - $18.5 Million	152,828 Added 9.19%	1,816,517 $196 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $157,394 - $175,346	1,496 Added 0.09%	1,663,689 $187 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $7.94 Million - $8.74 Million	77,634 Added 4.9%	1,662,193 $180 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $17 Million - $23 Million	211,240 Added 15.38%	1,584,559 $170 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $2.2 Million - $2.58 Million	25,611 Added 1.9%	1,373,319 $120 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $10.3 Million - $13.8 Million	140,482 Added 11.64%	1,347,708 $132 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $8.42 Million - $12.8 Million	130,564 Added 12.13%	1,207,226 $92 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $4.4 Million - $5.5 Million	60,948 Added 6.0%	1,076,662 $95.3 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $4.66 Million - $5.6 Million	73,938 Added 7.85%	1,015,714 $76.9 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $865,203 - $1.11 Million	13,169 Added 1.42%	941,776 $68.5 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $4.6 Million - $5.42 Million	59,688 Added 6.87%	928,607 $74.8 Million
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $15.3 Million - $18.9 Million	196,737 Added 29.27%	868,919 $80.1 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $3.39 Million - $3.76 Million	38,086 Added 6.01%	672,182 $63.6 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $3.35 Million - $3.97 Million	-37,367 Reduced 5.57%	634,096 $58.7 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $6.2 Million - $8.3 Million	67,397 Added 11.16%	671,463 $63.6 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $4.64 Million - $5.09 Million	51,798 Added 9.38%	604,066 $58.4 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $3.34 Million - $4.26 Million	-47,765 Reduced 7.96%	552,268 $49.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	600,033	600,033 $43.5 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Abb Vie Inc. Transaction History